Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
21.12
+0.87 (4.30%)
Jun 18, 2026, 4:00 PM EDT - Market closed
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $640.57 million as of June 18, 2026. Its market cap has increased by 30.35% in one year.
Market Cap
640.57M
Enterprise Value
415.61M
1-Year Change
30.35%
Ranking
Category
Stock Price
$21.12
Market Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $123.05M to $640.57M, an increase of 420.57%. That is a compound annual growth rate of 26.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 640.57M | -43.58% |
| Dec 31, 2025 | 1.14B | 52.12% |
| Dec 31, 2024 | 746.39M | 28.53% |
| Dec 29, 2023 | 580.73M | -6.38% |
| Dec 30, 2022 | 620.32M | -43.76% |
| Dec 31, 2021 | 1.10B | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GRAIL | 2.67B |
| GeneDx Holdings | 1.70B |
| NeoGenomics | 1.40B |
| CareDx | 1.26B |
| OPKO Health | 1.08B |
| Personalis | 1.06B |
| Fulgent Genetics | 517.18M |
| Myriad Genetics | 425.96M |